Abstract:Background: Benign prostatic hyperplasia (BPH) is a common condition in elderly males, characterised by urinary symptoms that can significantly affect the quality of life. Conventional treatment options often involve surgical and pharmacological interventions, which may result in adverse effects. This study aimed to assess the effectiveness of individualised homoeopathic treatment in managing BPH, with particular emphasis on the miasmatic background.
Materials and Methods: This retrospective observational study was conducted at the Geriatrics OPD of NHMC & Hospital, New Delhi. Data from BPH patients (n=50) aged 50 to 80 years, enrolled between May 2020 and April 2023, who had regular follow-ups for six months, IPSS >7, PSA ?4 ng/ml, PV >20 g/20cc/20 ml, were analysed. The primary outcome was evaluated using the International Prostate Symptom Score (IPSS), and secondary outcomes included prostatic weight and Residual Urine Volume (RUV). Statistical analysis employed paired t-tests to determine changes in these values.
Results: 72% of patients (n=36) exhibited a Minimally Important Difference (MID) of ?3.1 in IPSS. Common symptoms recorded were increased urination frequency (72%), urgency to urinate (69%), dribbling of urine (55%), weak urinary stream (48%), and urinary retention (42%). Post-treatment analysis demonstrated significant reductions in IPSS (25.9%, t=8.29) (MD= ?3.9 ±0.47, p < 0.001); mean prostatic weight (10.9%, t=6.27) (MD= ?6.08 ±0.97, p < 0.001) and RUV (13.3%, t=6.55) (MD= ?10.16 ±1.55, p < 0.001). The most prescribed remedies were Lycopodium clavatum (20%), Thuja occidentalis (16%), and Pulsatilla nigricans (16%). Miasmatic analysis revealed sycosis as the predominant miasm in 82% of patients.
Conclusion: This study provides encouraging preliminary evidence towards the effectiveness of Homoeopathy in addressing BPH as a safe, non-surgical, and efficacious solution. Miasmatic analysis, primarily indicating sycosis, highlights its relevance in BPH management. Further research, including randomised controlled trials, is warranted.